Gentian Diagnostics ASA

OB:GENT Stock Report

Market Cap: NOK 601.5m

Gentian Diagnostics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of GENT?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders1,575,82510.2%
VC/PE Firms1,803,36811.7%
General Public2,057,33813.3%
Private Companies4,404,07128.6%
Institutions5,581,74836.2%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 86.34% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
13.7%
Vatne Capital AS
2,110,224NOK 82.3m0%no data
11.7%
Kvantia AS
1,803,368NOK 70.3m0%47.11%
9.51%
Storebrand Asset Management AS
1,467,157NOK 57.2m0%0.19%
7.97%
Holta Invest AS
1,228,502NOK 47.9m0%29.68%
5.55%
Rasmussengruppen AS
855,916NOK 33.4m0%4.94%
4.86%
Bendik Sundrehagen
749,700NOK 29.2m0%no data
3.56%
Carpe Diem Afseth AS
548,389NOK 21.4m0%no data
3.4%
Schroder Investment Management Limited
523,631NOK 20.4m0%no data
2.83%
Skandinaviska Enskilda Banken AB, Asset Management Arm
436,251NOK 17.0m0%0.21%
2.34%
DNB Asset Management AS
361,291NOK 14.1m0%no data
2.27%
JPMorgan Chase & Co, Private Banking and Investment Banking Investments
350,000NOK 13.6m0%no data
2.08%
Viola AS
320,916NOK 12.5m0%no data
1.95%
Portia AS
300,000NOK 11.7m0%no data
1.9%
Johan Krefting
292,400NOK 11.4m0%no data
1.67%
Intertrade Shipping AS
257,716NOK 10.1m0%no data
1.52%
Cressida AS
235,000NOK 9.2m0%no data
1.48%
Equinor Asset Management ASA
227,880NOK 8.9m0%0.02%
1.43%
Runar Vatne
220,000NOK 8.6m0%no data
1.38%
Marstal As
212,407NOK 8.3m0%no data
1.36%
Tomas Settevik
210,465NOK 8.2m0%no data
1.36%
Mutus AS
210,465NOK 8.2m0%no data
1.35%
Salix As
208,954NOK 8.1m0%no data
0.85%
Norron AB
131,120NOK 5.1m0%0.34%
0.18%
Fredrik Thoresen
28,160NOK 1.1m0%no data
0.17%
Njaal Kind
26,125NOK 1.0m0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 10:40
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Gentian Diagnostics ASA is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David MartinssonDNB Markets
Geir HolomDNB Markets